- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05274620
Integrating a Suite of Mental Health Apps for Depression in a Healthcare Setting
July 18, 2022 updated by: Adaptive Health, Inc
The purpose of this study is to evaluate the implementation of IntelliCare as a frontline intervention within health care settings.
Study Overview
Detailed Description
This study will evaluate the implementation of IntelliCare in two settings: Primary care in the McLeod Health system, serving a rural population where mental healthcare workers are scarce, and Northwestern Medicine's Department of Psychiatry, which currently has a 9-month waitlist for psychological services.
Study Type
Interventional
Enrollment (Anticipated)
240
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: David Mohr, PhD
- Phone Number: 3125031403
- Email: d-mohr@northwestern.edu
Study Contact Backup
- Name: Andrea Graham, PhD
- Phone Number: 312-503-5266
- Email: andrea.graham@northwestern.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Not yet recruiting
- Northwestern Medicine Dept of Psychiatry
-
Contact:
- Jeff Rado, MD
- Phone Number: 312-695-5060
- Email: jeffrey.rado@nm.org
-
-
South Carolina
-
Florence, South Carolina, United States, 29506
- Recruiting
- MacLeod HealthCare
-
Contact:
- Brittany Rainwater, PsyD
- Phone Number: 843-777-2826
- Email: brittany.rainwater@mcleodhealth.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient who have been identified as depressed or anxious by a care provider in one of the participating healthcare organizations.
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: IntelliCare
8 weeks of IntelliCare
|
A mobile intervention that use principles of computerized therapy to decrease symptoms of depression
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reach
Time Frame: 5 months
|
1. Number of eligible patients during trial period; 2) number offered IntelliCare; 3) number initiating IntelliCare; 4) number completing IntelliCare
|
5 months
|
Cost
Time Frame: 7 months
|
Cost of delivering IntelliCare per patient
|
7 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Depression
Time Frame: Administered weekly over 8 weeks
|
Patient Health Questionnaire-9 (PHQ-9); higher scores indicate greater symptom severity
|
Administered weekly over 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Carolyn MacIver, Adaptive Health, Inc
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2022
Primary Completion (Anticipated)
August 31, 2023
Study Completion (Anticipated)
August 31, 2023
Study Registration Dates
First Submitted
March 2, 2022
First Submitted That Met QC Criteria
March 9, 2022
First Posted (Actual)
March 10, 2022
Study Record Updates
Last Update Posted (Actual)
July 20, 2022
Last Update Submitted That Met QC Criteria
July 18, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R44MH114725-05 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on IntelliCare
-
Camlin LtdUniversità Politecnica delle MarcheCompletedParkinson Disease | Post-COVID19Italy
-
Actualize TherapyUniversity of ArkansasCompletedDepression | Anxiety | Primary Health CareUnited States
-
Northwestern UniversityCompletedAnxiety Disorders | Major Depressive DisorderUnited States
-
Fondazione Policlinico Universitario Agostino Gemelli...CompletedStroke | Multiple Sclerosis | Parkinson DiseaseItaly
-
University of VirginiaUnknownDepression | Anxiety | Mental Health Wellness 1United States
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH)RecruitingDepression | Anxiety DisordersUnited States
-
Northwestern UniversityBrown UniversityActive, not recruiting
-
University of VirginiaNorthwestern UniversityActive, not recruitingEngagement, Patient | Depression, AnxietyUnited States
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH)CompletedToward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part IDepression, AnxietyUnited States
-
Northwestern UniversityNational Institute of Mental Health (NIMH)Completed